📋
What this means for you
AI-generated plain English summary
✓
# Understanding Dostarlimab for Endometrial Cancer
✓
What this medicine does:** Dostarlimab is a new treatment option for patients with advanced endometrial cancer (cancer of the uterus lining) that has come back or spread, specifically for those whose cancer has certain genetic markers called high microsatellite instability or mismatch repair deficiency—this medicine helps your immune system recognize and fight cancer cells.
✓
What you should do:** If you have been diagnosed with this type of advanced or recurring endometrial cancer, talk to your cancer doctor about whether dostarlimab might be a treatment option for you; your doctor can test your cancer to see if it has these specific genetic markers and determine if this medicine is right for your situation.
✓
Key takeaway:** This is an additional treatment choice now available for patients with certain types of advanced endometrial cancer who have already received other treatments, offering hope for people whose cancer has returned or spread.
Always speak to your doctor before making any changes to your health or treatment.
New Guidance: NICE
View official guidance ↗
View official guidance ↗
TA1189
📋 What this means for you: Speak to your GP or specialist to understand how this guidance affects your care.
Read full article on NICE ↗
This article summarises content originally published by NICE. PatientIQ provides independent plain English summaries.
More Cancer News
BBC Health
BBC Health
NICE
‘My cancer spread while I waited months for surgery’: The cost of England’s cancer…
10 Sep 2026
Very hot drinks may damage the food pipe and increase cancer risk
09 Sep 2026
Durvalumab with platinum-based chemotherapy, then with or without olaparib, for untreated advanced or recurrent…
09 Sep 2026